Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 91 AL 105

The Immunopathogenesis of Alzheimer's Disease Is Related to the Composition of Gut Microbiota

Leblhuber F, Ehrlich D, Steiner K, Geisler S, Fuchs D, Lanser L, Kurz K.

Nutrients. 2021 Jan 25;13(2):361. doi: 10.3390/nu13020361.

Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review

Zimetti F, Adorni MP, Marsillach J, Marchi C, Trentini A, Valacchi G, Cervellati C.

Oxid Med Cell Longev. 2021 Jan 8;2021:6695796. doi: 10.1155/2021/6695796. eCollection 2021.

The role of post-translational modifications in the regulation of MCL1

Li S, Guo W, Wu H.

Cell Signal. 2021 May;81:109933. doi: 10.1016/j.cellsig.2021.109933. Epub 2021 Jan 27.

Multi-pathogen infections and Alzheimer's disease

Vigasova D, Nemergut M, Liskova B, Damborsky J.

Microb Cell Fact. 2021 Jan 28;20(1):25. doi: 10.1186/s12934-021-01520-7.

APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer's

Yang A, Kantor B, Chiba-Falek O.

Int J Mol Sci. 2021 Jan 27;22(3):1244. doi: 10.3390/ijms22031244.

A review on advances of treatment modalities for Alzheimer's disease

Se Thoe E, Fauzi A, Tang YQ, Chamyuang S, Chia AYY.

Life Sci. 2021 Jul 1;276:119129. doi: 10.1016/j.lfs.2021.119129. Epub 2021 Jan 27.

TREM2, microglia, and Alzheimer's disease

Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Y.

Mech Ageing Dev. 2021 Apr;195:111438. doi: 10.1016/j.mad.2021.111438. Epub 2021 Jan 28.

Resilience in the suprachiasmatic nucleus: Implications for aging and Alzheimer's disease

Fernandez FX, Kaladchibachi S, Negelspach DC.

Exp Gerontol. 2021 May;147:111258. doi: 10.1016/j.exger.2021.111258. Epub 2021 Jan 28.

Defects in ubiquitination and NETosis and their associations with human diseases

Arneth B.

Pathology. 2021 Jun;53(4):439-445. doi: 10.1016/j.pathol.2020.10.014. Epub 2021 Jan 29.

Interaction of NF-κB and Wnt/β-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments

Liu X, Wang K, Wei X, Xie T, Lv B, Zhou Q, Wang X.

Neurochem Res. 2021 Apr;46(4):711-731. doi: 10.1007/s11064-021-03227-y. Epub 2021 Feb 1.

The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer's Disease

Bekdash RA.

Int J Mol Sci. 2021 Jan 28;22(3):1273. doi: 10.3390/ijms22031273.

β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy

Beato A, Gori A, Boucherle B, Peuchmaur M, Haudecoeur R.

J Med Chem. 2021 Feb 11;64(3):1392-1422. doi: 10.1021/acs.jmedchem.0c01887. Epub 2021 Feb 2.

Mass spectrometry analysis of tau and amyloid-beta in iPSC-derived models of Alzheimer's disease and dementia

Arber C, Alatza A, Leckey CA, Paterson RW, Zetterberg H, Wray S.

J Neurochem. 2021 Oct;159(2):305-317. doi: 10.1111/jnc.15315. Epub 2021 Mar 2.

History in perspective: How Alzheimer's Disease came to be where it is?

Ahmed TF, Ahmed A, Imtiaz F.

Brain Res. 2021 May 1;1758:147342. doi: 10.1016/j.brainres.2021.147342. Epub 2021 Feb 4.

Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review

Malafaia D, Albuquerque HMT, Silva AMS.

Eur J Med Chem. 2021 Mar 15;214:113209. doi: 10.1016/j.ejmech.2021.113209. Epub 2021 Jan 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias